Back
Freeport-McMoRan Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
62
FCX
Freeport-McMoRan
Last Price:
$43.85
Seasonality Move:
0.58%
Sell
37
ASND
Ascendis Pharma AS
Last Price:
$172.14
Seasonality Move:
13.12%
Buy
62
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy, Sell or Hold?
-
The current Freeport-McMoRan [FCX] share price is $44.46. The Score for FCX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
FCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $172.95. The Score for ASND is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $44.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $172.95The current trend is moderately bullish and ASND is experiencing slight selling pressure.
FCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.99 | Buy |
Relative Strength Index (14 RSI): | 68.28 | Buy |
Chaikin Money Flow: | 8585918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.14 - 42.18) | Buy |
Bollinger Bands (100): | (35.07 - 40.85) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.05 | Buy |
Relative Strength Index (14 RSI): | 53.34 | Buy |
Chaikin Money Flow: | -148025 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (163.66 - 176.78) | Buy |
Bollinger Bands (100): | (142.37 - 170.85) | Buy |
FCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.71 | Buy |
20-day SMA: | 41.16 | Buy |
50-day SMA: | 38.73 | Buy |
200-day SMA: | 40.76 | Buy |
8-day EMA: | 42.02 | Buy |
20-day EMA: | 41.09 | Buy |
50-day EMA: | 39.59 | Buy |
200-day EMA: | 40.2 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 174.88 | Sell |
20-day SMA: | 172.94 | Buy |
50-day SMA: | 165.85 | Buy |
200-day SMA: | 144.39 | Buy |
8-day EMA: | 174.22 | Sell |
20-day EMA: | 171.85 | Buy |
50-day EMA: | 165.9 | Buy |
200-day EMA: | 149.27 | Buy |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.54 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.47 per share, an increase this year of $2.37 per share, and an increase next year of $7.10 per share.
Freeport-McMoRan Technical Analysis
Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |